Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Liquidia Corp

NASDAQ: LQDA · Life Sciences · 16 alerts · CIK 1819576

Share price
$56.37Close, Nov 16
Market cap
$5.08B
Shares outstanding
90.11MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Liquidia Corp filings on SEC EDGAR ↗

7:01 AM ET 8-K
Financial Results

Liquidia Financial Results

Liquidia Corporation reported Q3 2026 financial results, highlighted by $222.7 million in YUTREPIA net product sales, a 31% increase over the prior quarter. The company recorded a net loss of $236.3 million, which was primarily driven by a $389.7 million litigation settlement charge to resolve all outstanding disputes with United Therapeutics. Liquidia ended the quarter with $396.1 million in cash and cash equivalents.

Term
Q3 2026

“Five quarters after launch, YUTREPIA has rapidly established a preferred product profile because physicians value the control and flexibility it gives them over each patient’s therapy. That affinity and broad adoption have proven durable and our business continues to grow in parallel. With the litigation now fully resolved, and YUTREPIA’S commercial availability secure, we can fully focus on cementing the value of YUTREPIA through Phase 4 studies in PAH that will position it as the best-in-class inhaled therapy and first-in-choice prostacyclin.”

Dr. Roger Jeffs, Liquidia’s Chief Executive Officer
4:32 PM ET Form 4
Insider Selling

Liquidia CAO Dana Boyle Sells $68.3K of Stock

Dana Boyle, CAO, sold 1,581 shares of Liquidia Corp at $43.19 a share, worth $68.3K in total on Oct 26, 2026. Shares held after the trade: 164,028 (-1.0%).

Value
$68.3K
Shares
1,581
Price
$43.19
Role
CAO
Holding change
-1.0%
Trade date
Oct 26, 2026
4:31 PM ET Form 4
Insider Selling

Liquidia Chief Business Officer Jason Adair Sells $29.7K of Stock

Jason Adair, Chief Business Officer, sold 688 shares of Liquidia Corp at $43.19 a share, worth $29.7K in total on Oct 26, 2026. Shares held after the trade: 177,269 (-0.4%).

Value
$29.7K
Shares
688
Price
$43.19
Role
Chief Business Officer
Holding change
-0.4%
Trade date
Oct 26, 2026
6:03 AM ET 8-K
Court & Legal Update

Liquidia Court & Legal Update

Liquidia Corporation entered into a global settlement agreement with United Therapeutics to resolve all ongoing patent infringement, trade secret, and antitrust litigation. Liquidia will make aggregate payments of $320.4 million to UTC ($175M net initial payment plus $145.4M in 2027 installments) while agreeing to remove the PH-ILD indication from its YUTREPIA label to maintain the product's availability for PAH patients.

Counterparty
United Therapeutics Corporation

“Today’s agreement fully resolves years of litigation and provides certainty to PAH patients that they can continue to access YUTREPIA, whose differentiated attributes have enabled its rapid adoption by physicians and patients since launch.”

Dr. Roger Jeffs, CEO
8:05 PM ET Form 4
Insider Selling

Liquidia General Counsel Russell Schundler Sells $390K of Stock

Russell Schundler, General Counsel, sold 13,692 shares of Liquidia Corp at $28.48 a share, worth $390K in total on Oct 12, 2026. Shares held after the trade: 602,841 (-2.2%).

Value
$390K
Shares
13,692
Price
$28.48
Role
General Counsel
Holding change
-2.2%
Trade date
Oct 12, 2026
8:04 PM ET Form 4
Insider Selling

Liquidia CMO Rajeev Saggar Sells $263K of Stock

Rajeev Saggar, CMO, sold 9,218 shares of Liquidia Corp at $28.48 a share, worth $263K in total on Oct 12, 2026. Shares held after the trade: 126,368 (-6.8%).

Value
$263K
Shares
9,218
Price
$28.48
Role
CMO
Holding change
-6.8%
Trade date
Oct 12, 2026
8:03 PM ET Form 4
Insider Selling

Liquidia Chief Commercial Officer Scott Moomaw Sells $252K of Stock

Scott Moomaw, Chief Commercial Officer, sold 8,863 shares of Liquidia Corp at $28.48 a share, worth $252K in total on Oct 12, 2026. Shares held after the trade: 181,487 (-4.7%).

Value
$252K
Shares
8,863
Price
$28.48
Role
Chief Commercial Officer
Holding change
-4.7%
Trade date
Oct 12, 2026
8:02 PM ET Form 4
Insider Selling

Liquidia Chief Human Resource Officer Sarah Krepp Sells $149K of Stock

Sarah Krepp, Chief Human Resource Officer, sold 5,245 shares of Liquidia Corp at $28.48 a share, worth $149K in total on Oct 12, 2026. Shares held after the trade: 115,241 (-4.4%).

Value
$149K
Shares
5,245
Price
$28.48
Role
Chief Human Resource Officer
Holding change
-4.4%
Trade date
Oct 12, 2026
8:01 PM ET Form 4
Insider Selling

Liquidia Chief Development Officer Sanjeev Khindri Sells $31.4K of Stock

Sanjeev Khindri, Chief Development Officer, sold 1,101 shares of Liquidia Corp at $28.48 a share, worth $31.4K in total on Oct 12, 2026. Shares held after the trade: 64,846 (-1.7%).

Value
$31.4K
Shares
1,101
Price
$28.48
Role
Chief Development Officer
Holding change
-1.7%
Trade date
Oct 12, 2026
8:01 PM ET Form 4
Insider Selling

Liquidia CFO and COO Michael Kaseta Sells $539K of Stock

Michael Kaseta, CFO and COO, sold 18,938 shares of Liquidia Corp at $28.48 a share, worth $539K in total on Oct 12, 2026. Shares held after the trade: 340,148 (-5.3%).

Value
$539K
Shares
18,938
Price
$28.48
Role
CFO and COO
Holding change
-5.3%
Trade date
Oct 12, 2026
8:00 PM ET Form 4
Insider Selling

Liquidia CEO Roger Jeffs Sells $933K of Stock

Roger Jeffs, CEO, sold 32,744 shares of Liquidia Corp at $28.48 a share, worth $933K in total on Oct 12, 2026. Shares held after the trade: 1,125,848 (-2.8%).

Value
$933K
Shares
32,744
Price
$28.48
Role
CEO
Holding change
-2.8%
Trade date
Oct 12, 2026
7:59 PM ET Form 4
Insider Selling

Liquidia CAO Dana Boyle Sells $168K of Stock

Dana Boyle, CAO, sold 5,892 shares of Liquidia Corp at $28.48 a share, worth $168K in total on Oct 12, 2026. Shares held after the trade: 165,609 (-3.4%).

Value
$168K
Shares
5,892
Price
$28.48
Role
CAO
Holding change
-3.4%
Trade date
Oct 12, 2026
7:59 PM ET Form 4
Insider Selling

Liquidia Chief Business Officer Jason Adair Sells $208K of Stock

Jason Adair, Chief Business Officer, sold 7,301 shares of Liquidia Corp at $28.48 a share, worth $208K in total on Oct 12, 2026. Shares held after the trade: 177,957 (-3.9%).

Value
$208K
Shares
7,301
Price
$28.48
Role
Chief Business Officer
Holding change
-3.9%
Trade date
Oct 12, 2026
4:30 PM ET Form 4
Insider Selling

Liquidia Insider Stephen M. Bloch Sells $6.39M of Stock

Stephen M. Bloch sold 235,477 shares of Liquidia Corp at $27.13 a share, worth $6.39M in total on Oct 5, 2026. Shares held after the trade: 0 (-100.0%).

Value
$6.39M
Shares
235,477
Price
$27.13
Holding change
-100.0%
Trade date
Oct 5, 2026
5:27 PM ET 8-K
Court & Legal Update

Liquidia Court & Legal Update

The U.S. District Court for the District of Delaware ruled that Liquidia's lead product, YUTREPIA, infringed on two valid claims of United Therapeutics' '327 patent. Liquidia intends to appeal the decision and may seek to remove the PH-ILD indication from its label to mitigate potential injunctive relief that could restrict the product's market availability.

Counterparty
United Therapeutics Corporation

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.